Shintaro Ohgake

Serum brain-derived neurotrophic factor (BDNF) levels in patients with panic disorder: As a biological predictor of response to group cognitive behavioral therapy

Keisuke Kobayashi, Eiji Shimizu, Kenji Hashimoto et al. · Progress in Neuro-Psychopharmacology and Biological Psychiatry · 2005 · 94 citations

Neuropsychology, Biological Predictor, Psychiatry +12

Association between the brain‐derived neurotrophic factor 196G/A polymorphism and eating disorders

Hiroki Koizumi, Kenji Hashimoto, Kanako Itoh et al. · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · 2003 · 74 citations

Glycine and d-serine, but not d-cycloserine, attenuate prepulse inhibition deficits induced by NMDA receptor antagonist MK-801

Nobuhisa Kanahara, Eiji Shimizu, Shintaro Ohgake et al. · Psychopharmacology · 2008 · 51 citations

Medicine, Physiology, Psychopharmacology +4

Synaptic Scaffolding Molecule <i>α</i> Is a Scaffold To Mediate <i>N</i>-Methyl-<scp>d</scp>-Aspartate Receptor-Dependent RhoA Activation in Dendrites

Junko Iida, Hiroyoshi Ishizaki, Miki Tanaka et al. · Molecular and Cellular Biology · 2007 · 45 citations · Full text

Dendritic Biology, Synaptic Transmission, Molecular Biology +21

No association of the brain-derived neurotrophic factor (BDNF) gene polymorphisms with panic disorder

Eiji Shimizu, Kenji Hashimoto, Hiroki Koizumi et al. · Progress in Neuro-Psychopharmacology and Biological Psychiatry · 2005 · 41 citations

Psychiatry, Neurobiological Factor, Neuropsychiatry +10